Dividendenbekanntmachungen (12.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALCOA CORPORATION US0138721065 0,1 USD 0,086 EUR AMERICAN WATER WORKS COMPANY INC US0304201033 0,8275 USD 0,7124 EUR CHEESECAKE... ► Artikel lesen |
FTAI Aviation Ltd. Reports Second Quarter 2025 Results, Declares Dividend of $0.30 per Ordinary Share | NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI) (the "Company" or "FTAI") today reported financial results for the second quarter 2025. The Company's consolidated comparative... ► Artikel lesen |
Dividendenbekanntmachungen (16.05.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADIDAS AG DE000A1EWWW0 - 2 EUR AF GRUPPEN ASA NO0003078107 5 NOK 0,4289 EUR AIXTRON SE DE000A0WMPJ6 - 0,15 EUR ALGOMA CENTRAL CORPORATION CA0156441077 0... ► Artikel lesen |
Flugtaxi-Entwickler Joby übernimmt Blade Air Mobility | Joby Aviation, ein von Toyota unterstützter Entwickler von elektrischen Lufttaxis aus Kalifornien, will das Passagiergeschäft des Hubschrauer-Vermittlers Blade Air Mobility für bis zu 125 Millionen... ► Artikel lesen |
Joby Aviation, Inc.: Joby to Acquire Blade's Passenger Business, Accelerating Air Taxi Commercialization | Up to $125 million acquisition of leading urban air mobility platform delivers dedicated terminal and lounge infrastructure in key urban markets in the U.S. and Europe, including New York City... ► Artikel lesen |
Blade Air Mobility, Inc.: Blade announces sale of Passenger Division to Joby, Transitions to Pure-Play Medical Services and Logistics Business | Blade Passenger division to be sold to Joby Aviation for up to $125 millionBlade's Medical division will remain public and rebrand as Strata post-close, focusing entirely on its rapidly growing contractual... ► Artikel lesen |
Cathie Wood ist investiert: Shortseller läutet Alarm: Wird Archer Aviation zur Luftnummer? | © Foto: ASSOCIATED PRESS | Michel Euler - picture allianceArcher Aviation gerät ins Kreuzfeuer. Ein Shortseller zieht Parallelen zu Nikola. Rivale Joby punktet dagegen mit Zertifizierungsfortschritten.... ► Artikel lesen |
Argenx's VYVGART Achieves Primary Endpoint In Pivotal Study For AChR-Ab Seronegative GMG | AMSTERDAM (dpa-AFX) - argenx SE (ARGX) reported that the pivotal ADAPT SERON study of VYVGART (IV: efgartigimod alfa-fcab) successfully met its primary endpoint. The study demonstrated a statistically... ► Artikel lesen |
argenx SE: argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG | Study met primary endpoint (p-value=0.0068) First global phase 3 study to demonstrate clinically meaningful improvements in disease activity across all three subtypes - MuSK+, LRP4+, triple seronegative... ► Artikel lesen |